OrbiMed’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$1.33M Hold
2024
Q4
$2.77M Hold
2024
Q3
$5.88M Buy
2024
Q2
$4.45M Hold
2024
Q1
$9.95M Buy
2023
Q4
$1.98M Buy
2016
Q2
Sell
2016
Q1
$1.25M Hold
2015
Q4
$2.33M Hold
2015
Q3
$3.69M Hold
2015
Q2
$4.48M Hold
2015
Q1
$3.39M Hold
2014
Q4
$3.48M Hold
2014
Q3
$3.53M Hold
2014
Q2
$4.37M Hold
2014
Q1
$6.75M Sell
2013
Q4
$4.41M Buy